Advances in the pathology of breast in China over the past ten years: retrospect and prospect
10.3760/cma.j.cn112151-20250808-00545
- VernacularTitle:我国乳腺病理学近十年的回顾与展望
- Author:
Yueping LIU
1
;
Huaye DING
;
Hong BU
;
Wentao YANG
Author Information
1. 河北医科大学第四医院 河北省肿瘤医院病理科，石家庄 050011
- Publication Type:Journal Article
- Keywords:
Breast neoplasms;
Pathology;
Retrospect and prospect
- From:
Chinese Journal of Pathology
2025;54(11):1130-1135
- CountryChina
- Language:Chinese
-
Abstract:
In the past decade, breast pathology in China has made significant progress in diagnostic standards, technological applications, scientific research, and discipline development. The histopathological diagnostic system has been continuously refined, with the implementation of relevant guidelines and expert consensus enhancing standardization and reproducibility of diagnostic results. Immunohistochemistry and molecular testing technologies have become increasingly sophisticated, with emerging biomarkers such as low HER2 expression and PIK3CA mutations gradually integrated into clinical decision-making, promoting the advancement of precision therapy. The application of digital pathology and image-assisted analysis has steadily expanded, providing new tools to improve diagnostic efficiency and consistency. The national breast pathology group has actively advanced the development of tiered diagnostic systems, workforce training, and public education, effectively strengthening diagnostic capabilities at the grassroots level. Looking ahead, the integration of multidimensional data, optimization of auxiliary diagnostic systems, and interdisciplinary collaboration are expected to drive the continued development of breast pathology in China.
